Geranylgeranylacetone

183+ PubMed studies analyzed · BiohacksAI corpus v20260307-01

PubMed Studies

183+

Targets

Pathways

Molecular Targets

CYP2C9 NFE2L2 IFNG NR1I2

Molecular targets identified in BiohacksAI corpus. Click to explore all compounds affecting each target.

Biological Pathways

INFLAMMATION APOPTOSIS PROTEOSTASIS NEUROTROPHIC INSULIN_SIGNALING OXIDATIVE_STRESS NITRIC_OXIDE LIPID_METABOLISM MITOCHONDRIA SENESCENCE

Biological pathways associated with Geranylgeranylacetone based on target analysis.

Biological Mechanisms

NF-κBNF-κB BDNFBDNF IRSInsulin Signaling NRF2Nrf2 NONitric Oxide PGC-1αMitochondrial Biogenesis

Biological mechanisms activated or modulated by Geranylgeranylacetone based on pathway and target analysis.

Health Goals

Inflammation →Longevity →Memory →Neuroprotection →Energy →

Health goals where Geranylgeranylacetone ranks among evidence-based compounds in the BiohacksAI corpus.

Related Conditions

Chronic Inflammation →Arthritis →Alzheimer's →Depression →Type 2 Diabetes →

Health conditions associated with the biological pathways influenced by Geranylgeranylacetone.

External References

PubChem CID 5282199 →183 PubMed studies →

Similar Compounds

Explore compounds with similar target profiles and pathway overlap.

Data Source

Corpusv20260307-01

PubMed studies183

PubChem CID5282199

SourcePubMed / NCBI · ChEMBL · Reactome · PubChem

All data is computationally derived from published research. Molecular structure images from PubChem (public domain). Not medical advice. Independent validation required.

This compound profile for Geranylgeranylacetone is generated from 183 PubMed-indexed studies. Key molecular targets include CYP2C9, NFE2L2, IFNG. Associated biological pathways: INFLAMMATION, APOPTOSIS, PROTEOSTASIS. BiohacksAI does not provide medical advice. Consult a healthcare professional before starting any supplement regimen.